ID   SREA_NEUCR              Reviewed;         587 AA.
AC   Q1K8E7;
DT   20-JUN-2018, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 1.
DT   07-APR-2021, entry version 59.
DE   RecName: Full=GATA-type transcription factor sre {ECO:0000303|PubMed:9790585};
DE   AltName: Full=Siderophore uptake regulator sreA {ECO:0000303|PubMed:9790585};
GN   Name=sre {ECO:0000303|PubMed:9790585}; ORFNames=NCU07728;
OS   Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 /
OS   FGSC 987).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Sordariomycetidae; Sordariales; Sordariaceae; Neurospora.
OX   NCBI_TaxID=367110;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987;
RX   PubMed=12712197; DOI=10.1038/nature01554;
RA   Galagan J.E., Calvo S.E., Borkovich K.A., Selker E.U., Read N.D.,
RA   Jaffe D.B., FitzHugh W., Ma L.-J., Smirnov S., Purcell S., Rehman B.,
RA   Elkins T., Engels R., Wang S., Nielsen C.B., Butler J., Endrizzi M.,
RA   Qui D., Ianakiev P., Bell-Pedersen D., Nelson M.A., Werner-Washburne M.,
RA   Selitrennikoff C.P., Kinsey J.A., Braun E.L., Zelter A., Schulte U.,
RA   Kothe G.O., Jedd G., Mewes H.-W., Staben C., Marcotte E., Greenberg D.,
RA   Roy A., Foley K., Naylor J., Stange-Thomann N., Barrett R., Gnerre S.,
RA   Kamal M., Kamvysselis M., Mauceli E.W., Bielke C., Rudd S., Frishman D.,
RA   Krystofova S., Rasmussen C., Metzenberg R.L., Perkins D.D., Kroken S.,
RA   Cogoni C., Macino G., Catcheside D.E.A., Li W., Pratt R.J., Osmani S.A.,
RA   DeSouza C.P.C., Glass N.L., Orbach M.J., Berglund J.A., Voelker R.,
RA   Yarden O., Plamann M., Seiler S., Dunlap J.C., Radford A., Aramayo R.,
RA   Natvig D.O., Alex L.A., Mannhaupt G., Ebbole D.J., Freitag M., Paulsen I.,
RA   Sachs M.S., Lander E.S., Nusbaum C., Birren B.W.;
RT   "The genome sequence of the filamentous fungus Neurospora crassa.";
RL   Nature 422:859-868(2003).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION.
RX   PubMed=9790585; DOI=10.1007/s004380050845;
RA   Zhou L.W., Haas H., Marzluf G.A.;
RT   "Isolation and characterization of a new gene, sre, which encodes a GATA-
RT   type regulatory protein that controls iron transport in Neurospora
RT   crassa.";
RL   Mol. Gen. Genet. 259:532-540(1998).
RN   [3]
RP   FUNCTION, DNA-BINDING, DOMAIN, AND MUTAGENESIS OF 284-ASN--GLY-286 AND
RP   305-ALA-CYS-306.
RX   PubMed=10194352; DOI=10.1021/bi982543f;
RA   Zhou L., Marzluf G.A.;
RT   "Functional analysis of the two zinc fingers of SRE, a GATA-type factor
RT   that negatively regulates siderophore synthesis in Neurospora crassa.";
RL   Biochemistry 38:4335-4341(1999).
RN   [4]
RP   FUNCTION, DNA-BINDING, DOMAIN, AND MUTAGENESIS OF CYS-204; CYS-210; CYS-219
RP   AND CYS-222.
RX   PubMed=12484767; DOI=10.1021/bi0204995;
RA   Harrison K.A., Marzluf G.A.;
RT   "Characterization of DNA binding and the cysteine rich region of SRE, a
RT   GATA factor in Neurospora crassa involved in siderophore synthesis.";
RL   Biochemistry 41:15288-15295(2002).
CC   -!- FUNCTION: GATA-type transcription repressor that regulates
CC       iron- acquisition genes through specific binding the GATA sequence
CC       elements of target promoters in a zinc-dependent manner
CC       (PubMed:9790585, PubMed:10194352, PubMed:12484767). Iron acquisition
CC       regulation is critical for survival under both iron-limiting conditions
CC       (to acquire essential iron) and iron-replete conditions (to limit iron
CC       toxicity) (PubMed:10194352). Represses the synthesis of siderophores in
CC       high iron conditions (PubMed:9790585). {ECO:0000269|PubMed:10194352,
CC       ECO:0000269|PubMed:12484767, ECO:0000269|PubMed:9790585}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- INDUCTION: The promoter contains a number of GATA sequences; however,
CC       expression occurs in a constitutive fashion and is not regulated by the
CC       concentration of iron available to the cells (PubMed:9790585).
CC       {ECO:0000269|PubMed:9790585}.
CC   -!- DOMAIN: The conserved cystein-rich region (CRR) localized between the
CC       zinc fingers is also involved in DNA-binding and transcription
CC       repressor activity (PubMed:12484767). {ECO:0000269|PubMed:12484767}.
CC   -!- DOMAIN: Both the N-terminal and C-terminal zinc fingers are involved in
CC       DNA-binding, although the C-terminal finger plays a more important role
CC       in the binding (PubMed:10194352). {ECO:0000269|PubMed:10194352}.
CC   -!- DISRUPTION PHENOTYPE: Derepresses siderophore biosynthesis in high iron
CC       concentrations (PubMed:9790585). {ECO:0000269|PubMed:9790585}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CM002239; EAA32742.1; -; Genomic_DNA.
DR   RefSeq; XP_961978.1; XM_956885.2.
DR   SMR; Q1K8E7; -.
DR   EnsemblFungi; EAA32742; EAA32742; NCU07728.
DR   GeneID; 3878126; -.
DR   KEGG; ncr:NCU07728; -.
DR   VEuPathDB; FungiDB:NCU07728; -.
DR   HOGENOM; CLU_021761_1_0_1; -.
DR   InParanoid; Q1K8E7; -.
DR   OMA; CYRPTTM; -.
DR   Proteomes; UP000001805; Chromosome 4, Linkage Group IV.
DR   Proteomes; UP000001805; Unassembled WGS sequence.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd00202; ZnF_GATA; 2.
DR   Gene3D; 3.30.50.10; -; 2.
DR   InterPro; IPR039355; Transcription_factor_GATA.
DR   InterPro; IPR000679; Znf_GATA.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR10071; PTHR10071; 1.
DR   Pfam; PF00320; GATA; 2.
DR   PRINTS; PR00619; GATAZNFINGER.
DR   SMART; SM00401; ZnF_GATA; 2.
DR   PROSITE; PS00344; GATA_ZN_FINGER_1; 2.
DR   PROSITE; PS50114; GATA_ZN_FINGER_2; 2.
PE   1: Evidence at protein level;
KW   Coiled coil; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..587
FT                   /note="GATA-type transcription factor sre"
FT                   /id="PRO_0000444399"
FT   ZN_FING         118..142
FT                   /note="GATA-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00094"
FT   ZN_FING         282..306
FT                   /note="GATA-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00094"
FT   REGION          204..222
FT                   /note="Cystein-rich region (CRR)"
FT                   /evidence="ECO:0000269|PubMed:12484767"
FT   COILED          553..585
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         204
FT                   /note="C->S: Decreases DNA-binding and fails to exhibit
FT                   iron-mediated regulation of siderophore synthesis; when
FT                   associated with S-210."
FT                   /evidence="ECO:0000269|PubMed:12484767"
FT   MUTAGEN         210
FT                   /note="C->S: Decreases DNA-binding and fails to exhibit
FT                   iron-mediated regulation of siderophore synthesis; when
FT                   associated with S-204."
FT                   /evidence="ECO:0000269|PubMed:12484767"
FT   MUTAGEN         219
FT                   /note="C->S: Decreases DNA-binding and fails to exhibit
FT                   iron-mediated regulation of siderophore synthesis; when
FT                   associated with S-222."
FT                   /evidence="ECO:0000269|PubMed:12484767"
FT   MUTAGEN         222
FT                   /note="C->S: Decreases DNA-binding and fails to exhibit
FT                   iron-mediated regulation of siderophore synthesis; when
FT                   associated with S-219."
FT                   /evidence="ECO:0000269|PubMed:12484767"
FT   MUTAGEN         284..286
FT                   /note="NCG->LAF: Decreases the DNA-binding and the
FT                   subsequent transcription repressor activity."
FT                   /evidence="ECO:0000269|PubMed:10194352"
FT   MUTAGEN         305..306
FT                   /note="AC->EL: Decreases the DNA-binding and the subsequent
FT                   transcription repressor activity."
FT                   /evidence="ECO:0000269|PubMed:10194352"
SQ   SEQUENCE   587 AA;  62014 MW;  B0DFC7215DB97829 CRC64;
     MALPDDTRLM NNQTSIEGNS APDRMALPSR PPPPTASNEP PEHESTGPVD EAASKSESGL
     SPNSKKAGHA AQSPSGRKKS PKIQNAQPAQ SPAETVGVVN VATLGLVPSV QGHAGQVCSN
     CGTTHTPLWR RSPQGAIICN ACGLYLKARN AARPANIRRP PSVMASNVRQ AAAKLSPKKA
     TAPLLPSNPG ATYVAADQTP SGSCPGGGRC NGTGGAEGCG GCPAYNNRVS KSASLNVLKC
     QGAAAASSKK PQAAEGSGEE PTEMDITALH VQSQNTTVVI ACQNCGTTIT PLWRRDEAGH
     TICNACGLYY KLHGVHRPVT MKKAIIKRRK RVIPAAGGDA EIEPSEAPDS PPATSEPPME
     KGTVNEDGSV NLGIRRRSVR PLTLVPEDEL RRNRQASPLS SAALGQYHSS HTNQPHHGAH
     ASLTYENRLA PIHSLALPVD RQASISPASF LSPSRKRSIS AVENEPSSHN DNESHKRLSS
     IKSILNPMPS SEIHREVSPA DQLRMQPASR SPAMSSLTPA HSPGSFSNST VIGTPTSAPI
     LRSASRDTHN DSERMKAERR AALEREAEMM RELLAAKERE LAELGYD
//
